The vials used for the Pfizer-BioNTech, Moderna and AstraZeneca coronavirus (COVID-19) vaccines are pictured on February 17, 2021 at the immunization center at Malmোর Scan University Hospital in Sweden. (Sweden out via Reuters)
STOCKHOLM (Reuters) – Sweden’s public health agency said on Monday it had recommended the use of a vaccine against rival Modern SpikeVax against Pfizer-Biotech, Covid-1.
The European Medicines Agency approved the use of Camirna in May, while SpikeVax was approved in July for children over 12 years of age.
“All in all, we see one of the reasons we chose the vaccine that we know the most, and it’s proven to be the best when it comes to vaccinating children between the ages of 12 and 15,” said Dr. Anders Tegnel, department head and state epidemiologist at the health agency.
The agency said it had more information on the use of camomile on children.
“That’s why SpikeVax is not recommended for Sweden’s youngest age,” the agency said in a statement.
In September, the agency said children 12 years of age or older would be vaccinated with a COVID vaccine from 11 October.
Written by Simon Jansor
This News Originally From – The Epoch Times